Welcome to Mælandsmo's Group
The research group is studying biological and therapeutic aspects of the metastatic process, the principle cause of death in cancer patients. Our goal is to extend the knowledge about how the individual steps in this complicated process are regulated, and subsequently use this information for identification of potential target molecules that can be utilized in cancer therapy.
Professor Gunhild M. Mælandsmo, who is the administrative group leader.
The group is member of the Center for Research Based Innovation, Cancer Stem Cell Innovation Center (CAST)., and the K.G. Jebsen centre for Breast Cancer Research http://www.med.uio.no/klinmed/forskning/sentre/kgj-brystkreftforskning/om/kontakt/.
Contact information
The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
Phone: +47 22 78 18 79(Mælandsmo) Fax: +47 22 78 17 95
Email: gunhildm@rr-research.no
Focus on recruitment and career building in health research
May 24, 2013
Latest publications
Metastasis: biology and therapy group
Hypoxic Tumor Kinase Signaling Mediated by STAT5A in Development of Castration-Resistant Prostate Cancer
PLoS One, 8 (5), e63723
PubMed 23675504
Magnetic resonance-guided histopathology for improved accuracy of tumor response evaluation of neoadjuvant treatment in organ-infiltrating rectal cancer
Radiother Oncol (in press)
PubMed 23602370
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
Breast Cancer Res, 15 (1), R16 (in press)
PubMed 23448424
More publications





Print this page
